Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis

A. Bardoni, P. Rossi, R. Salvini, F. Bobbio-Pallavicini, R. Caporali, Carlomaurizio Montecucco

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objective. To assess the frequency and clinical correlates of the systemic sclerosis-related autoantibodies to RNA polymerases in Italian patients. Methods. Sera from 115 patients with systemic sclerosis (SSc) and 10 patients with systemic sclerosis-overlap syndromes recruited from a single center in northern Italy were investigated for antibodies to RNA polymerase I, II, and III by means of immunoprecipitation using 35S-labeled HeLa cell antigen extract. Twenty-five normal volunteers and 91 patients with different connective tissue diseases were studied as a control group. Results. Antibodies to RNA-polymerases were found in 14/115 SSc patients (12.1%). None of the normal controls and none of the patients with other connective tissue diseases, including overlap syndromes, were positive. Antibodies reacting with RNA-polymerase I and III (± RNA-polymerase II) were found in 9/115 patients (7.8%) and were mutually exclusive with respect to other scleroderma-related autoantibodies. Isolated anti-RNA polymerase II reactivity was found in 5 patients and was associated with anti-topoisomerase I antibodies in 4 cases. Anti-RNA-polymerase I and III antibodies were associated with diffuse cutaneous involvement and male gender. Only two patients from our series had scleroderma renal crisis, and one of them had anti-RNA polymerase antibodies. Conclusions. Anti-RNA-polymerase antibodies appear to be less frequent in Italian patients than in Caucasian patients from the United Kingdom or USA. This might be associated with the lower frequency of scleroderma renal crisis.

Original languageEnglish
Pages (from-to)301-306
Number of pages6
JournalClinical and Experimental Rheumatology
Volume21
Issue number3
Publication statusPublished - May 2003

Fingerprint

Systemic Scleroderma
DNA-Directed RNA Polymerases
Autoantibodies
RNA Polymerase I
RNA Polymerase III
Antibodies
RNA Polymerase II
Kidney
Type I DNA Topoisomerase
Connective Tissue Diseases
Cell Extracts
HeLa Cells
Immunoprecipitation
Italy
Healthy Volunteers
Antigens

Keywords

  • Autoantibodies
  • Connective tissue disease
  • RNA-polymerases
  • Scleroderma renal crisis
  • Systemic sclerosis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. / Bardoni, A.; Rossi, P.; Salvini, R.; Bobbio-Pallavicini, F.; Caporali, R.; Montecucco, Carlomaurizio.

In: Clinical and Experimental Rheumatology, Vol. 21, No. 3, 05.2003, p. 301-306.

Research output: Contribution to journalArticle

@article{2cf81b8a4cdf4a2d8eed58c4bf9f374d,
title = "Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis",
abstract = "Objective. To assess the frequency and clinical correlates of the systemic sclerosis-related autoantibodies to RNA polymerases in Italian patients. Methods. Sera from 115 patients with systemic sclerosis (SSc) and 10 patients with systemic sclerosis-overlap syndromes recruited from a single center in northern Italy were investigated for antibodies to RNA polymerase I, II, and III by means of immunoprecipitation using 35S-labeled HeLa cell antigen extract. Twenty-five normal volunteers and 91 patients with different connective tissue diseases were studied as a control group. Results. Antibodies to RNA-polymerases were found in 14/115 SSc patients (12.1{\%}). None of the normal controls and none of the patients with other connective tissue diseases, including overlap syndromes, were positive. Antibodies reacting with RNA-polymerase I and III (± RNA-polymerase II) were found in 9/115 patients (7.8{\%}) and were mutually exclusive with respect to other scleroderma-related autoantibodies. Isolated anti-RNA polymerase II reactivity was found in 5 patients and was associated with anti-topoisomerase I antibodies in 4 cases. Anti-RNA-polymerase I and III antibodies were associated with diffuse cutaneous involvement and male gender. Only two patients from our series had scleroderma renal crisis, and one of them had anti-RNA polymerase antibodies. Conclusions. Anti-RNA-polymerase antibodies appear to be less frequent in Italian patients than in Caucasian patients from the United Kingdom or USA. This might be associated with the lower frequency of scleroderma renal crisis.",
keywords = "Autoantibodies, Connective tissue disease, RNA-polymerases, Scleroderma renal crisis, Systemic sclerosis",
author = "A. Bardoni and P. Rossi and R. Salvini and F. Bobbio-Pallavicini and R. Caporali and Carlomaurizio Montecucco",
year = "2003",
month = "5",
language = "English",
volume = "21",
pages = "301--306",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "3",

}

TY - JOUR

T1 - Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis

AU - Bardoni, A.

AU - Rossi, P.

AU - Salvini, R.

AU - Bobbio-Pallavicini, F.

AU - Caporali, R.

AU - Montecucco, Carlomaurizio

PY - 2003/5

Y1 - 2003/5

N2 - Objective. To assess the frequency and clinical correlates of the systemic sclerosis-related autoantibodies to RNA polymerases in Italian patients. Methods. Sera from 115 patients with systemic sclerosis (SSc) and 10 patients with systemic sclerosis-overlap syndromes recruited from a single center in northern Italy were investigated for antibodies to RNA polymerase I, II, and III by means of immunoprecipitation using 35S-labeled HeLa cell antigen extract. Twenty-five normal volunteers and 91 patients with different connective tissue diseases were studied as a control group. Results. Antibodies to RNA-polymerases were found in 14/115 SSc patients (12.1%). None of the normal controls and none of the patients with other connective tissue diseases, including overlap syndromes, were positive. Antibodies reacting with RNA-polymerase I and III (± RNA-polymerase II) were found in 9/115 patients (7.8%) and were mutually exclusive with respect to other scleroderma-related autoantibodies. Isolated anti-RNA polymerase II reactivity was found in 5 patients and was associated with anti-topoisomerase I antibodies in 4 cases. Anti-RNA-polymerase I and III antibodies were associated with diffuse cutaneous involvement and male gender. Only two patients from our series had scleroderma renal crisis, and one of them had anti-RNA polymerase antibodies. Conclusions. Anti-RNA-polymerase antibodies appear to be less frequent in Italian patients than in Caucasian patients from the United Kingdom or USA. This might be associated with the lower frequency of scleroderma renal crisis.

AB - Objective. To assess the frequency and clinical correlates of the systemic sclerosis-related autoantibodies to RNA polymerases in Italian patients. Methods. Sera from 115 patients with systemic sclerosis (SSc) and 10 patients with systemic sclerosis-overlap syndromes recruited from a single center in northern Italy were investigated for antibodies to RNA polymerase I, II, and III by means of immunoprecipitation using 35S-labeled HeLa cell antigen extract. Twenty-five normal volunteers and 91 patients with different connective tissue diseases were studied as a control group. Results. Antibodies to RNA-polymerases were found in 14/115 SSc patients (12.1%). None of the normal controls and none of the patients with other connective tissue diseases, including overlap syndromes, were positive. Antibodies reacting with RNA-polymerase I and III (± RNA-polymerase II) were found in 9/115 patients (7.8%) and were mutually exclusive with respect to other scleroderma-related autoantibodies. Isolated anti-RNA polymerase II reactivity was found in 5 patients and was associated with anti-topoisomerase I antibodies in 4 cases. Anti-RNA-polymerase I and III antibodies were associated with diffuse cutaneous involvement and male gender. Only two patients from our series had scleroderma renal crisis, and one of them had anti-RNA polymerase antibodies. Conclusions. Anti-RNA-polymerase antibodies appear to be less frequent in Italian patients than in Caucasian patients from the United Kingdom or USA. This might be associated with the lower frequency of scleroderma renal crisis.

KW - Autoantibodies

KW - Connective tissue disease

KW - RNA-polymerases

KW - Scleroderma renal crisis

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0037534438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037534438&partnerID=8YFLogxK

M3 - Article

C2 - 12846047

AN - SCOPUS:0037534438

VL - 21

SP - 301

EP - 306

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 3

ER -